nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—Sirolimus—EIF4E—autistic disorder	0.045	1	CrCbGaD
Everolimus—MTOR—hindbrain—autistic disorder	0.0376	0.12	CbGeAlD
Everolimus—MTOR—brainstem—autistic disorder	0.0215	0.0685	CbGeAlD
Everolimus—MTOR—eye—autistic disorder	0.021	0.0667	CbGeAlD
Everolimus—MTOR—forebrain—autistic disorder	0.0208	0.0661	CbGeAlD
Everolimus—MTOR—telencephalon—autistic disorder	0.0191	0.0608	CbGeAlD
Everolimus—FKBP1A—eye—autistic disorder	0.0189	0.06	CbGeAlD
Everolimus—FKBP1A—forebrain—autistic disorder	0.0187	0.0595	CbGeAlD
Everolimus—FKBP1A—telencephalon—autistic disorder	0.0172	0.0547	CbGeAlD
Everolimus—MTOR—digestive system—autistic disorder	0.0146	0.0464	CbGeAlD
Everolimus—FKBP1A—digestive system—autistic disorder	0.0131	0.0417	CbGeAlD
Everolimus—MTOR—head—autistic disorder	0.0119	0.0379	CbGeAlD
Everolimus—MTOR—nervous system—autistic disorder	0.0113	0.0359	CbGeAlD
Everolimus—MTOR—central nervous system—autistic disorder	0.0109	0.0345	CbGeAlD
Everolimus—FKBP1A—head—autistic disorder	0.0107	0.034	CbGeAlD
Everolimus—MTOR—cerebellum—autistic disorder	0.0106	0.0338	CbGeAlD
Everolimus—FKBP1A—nervous system—autistic disorder	0.0101	0.0323	CbGeAlD
Everolimus—FKBP1A—central nervous system—autistic disorder	0.00977	0.0311	CbGeAlD
Everolimus—FKBP1A—cerebellum—autistic disorder	0.00955	0.0304	CbGeAlD
Everolimus—MTOR—brain—autistic disorder	0.00862	0.0274	CbGeAlD
Everolimus—FKBP1A—brain—autistic disorder	0.00776	0.0247	CbGeAlD
Everolimus—CYP3A4—digestive system—autistic disorder	0.00429	0.0136	CbGeAlD
Everolimus—CYP3A4—nervous system—autistic disorder	0.00332	0.0105	CbGeAlD
Everolimus—CYP3A4—central nervous system—autistic disorder	0.00319	0.0102	CbGeAlD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—autistic disorder	0.000363	0.000567	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—IL6—autistic disorder	0.000361	0.000564	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—MAPK1—autistic disorder	0.000361	0.000564	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—MAPK1—autistic disorder	0.000359	0.000561	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—IL6—autistic disorder	0.000359	0.00056	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—MAPK1—autistic disorder	0.000358	0.000558	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—MAPK1—autistic disorder	0.000358	0.000558	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—MAPK1—autistic disorder	0.000356	0.000556	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—MAPK1—autistic disorder	0.000354	0.000553	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GABBR2—autistic disorder	0.00035	0.000547	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GZMB—autistic disorder	0.000347	0.000541	CbGpPWpGaD
Everolimus—MTOR—Immune System—EIF4E—autistic disorder	0.000343	0.000536	CbGpPWpGaD
Everolimus—MTOR—Immune System—PARK2—autistic disorder	0.000338	0.000527	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR1B—autistic disorder	0.000337	0.000525	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—OXT—autistic disorder	0.000337	0.000525	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—MAPK1—autistic disorder	0.000333	0.00052	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MAPK1—autistic disorder	0.000333	0.00052	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—MAPK1—autistic disorder	0.000333	0.00052	CbGpPWpGaD
Everolimus—MTOR—Disease—RPL10—autistic disorder	0.000332	0.000518	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—MAPK1—autistic disorder	0.00033	0.000515	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—MAPK1—autistic disorder	0.000327	0.000511	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—MAPK1—autistic disorder	0.000326	0.000509	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—HRAS—autistic disorder	0.000321	0.000501	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—HRAS—autistic disorder	0.000315	0.000492	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—MEF2C—autistic disorder	0.000315	0.000492	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TSC1—autistic disorder	0.000313	0.000488	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD1—autistic disorder	0.000313	0.000488	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR1D—autistic disorder	0.000312	0.000488	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—IL6—autistic disorder	0.000307	0.000479	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—HRAS—autistic disorder	0.000307	0.000479	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NTRK2—autistic disorder	0.000304	0.000475	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD3—autistic disorder	0.000303	0.000473	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—HRAS—autistic disorder	0.000302	0.000472	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	0.000301	0.00047	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRLR—autistic disorder	0.000301	0.000469	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL5—autistic disorder	0.000297	0.000463	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—MAPK1—autistic disorder	0.000295	0.000461	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—IL6—autistic disorder	0.000294	0.000459	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CALCA—autistic disorder	0.000293	0.000457	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GRM8—autistic disorder	0.00029	0.000453	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—HRAS—autistic disorder	0.00029	0.000453	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—IL6—autistic disorder	0.000289	0.000451	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—HRAS—autistic disorder	0.000289	0.00045	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—autistic disorder	0.000287	0.000448	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—HRAS—autistic disorder	0.000287	0.000448	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—HRAS—autistic disorder	0.000286	0.000446	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—HRAS—autistic disorder	0.000284	0.000444	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—WNT2—autistic disorder	0.000281	0.000439	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—autistic disorder	0.00028	0.000437	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—PTEN—autistic disorder	0.000279	0.000436	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GHR—autistic disorder	0.000277	0.000432	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—IL6—autistic disorder	0.000276	0.000431	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—IL6—autistic disorder	0.000275	0.000429	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-A—autistic disorder	0.000274	0.000428	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MTHFR—autistic disorder	0.000274	0.000427	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—IL6—autistic disorder	0.000273	0.000427	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDE4A—autistic disorder	0.000273	0.000426	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HLA-A—autistic disorder	0.000273	0.000426	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TSC2—autistic disorder	0.000272	0.000425	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—IL6—autistic disorder	0.000272	0.000425	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—HRAS—autistic disorder	0.000267	0.000418	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—autistic disorder	0.000267	0.000418	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—HRAS—autistic disorder	0.000267	0.000418	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	0.000266	0.000415	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—HRAS—autistic disorder	0.000265	0.000414	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1RN—autistic disorder	0.000264	0.000411	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—HRAS—autistic disorder	0.000263	0.00041	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	0.000262	0.00041	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—HRAS—autistic disorder	0.000262	0.000408	CbGpPWpGaD
Everolimus—MTOR—Disease—DHFR—autistic disorder	0.000262	0.000408	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—TSC2—autistic disorder	0.000261	0.000408	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TSC2—autistic disorder	0.00026	0.000406	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PRL—autistic disorder	0.000259	0.000404	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL5—autistic disorder	0.000258	0.000403	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—autistic disorder	0.000256	0.0004	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—IL6—autistic disorder	0.000256	0.0004	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—IL6—autistic disorder	0.000256	0.0004	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AVPR1A—autistic disorder	0.000256	0.000399	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APOE—autistic disorder	0.000255	0.000398	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—IL6—autistic disorder	0.000254	0.000396	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—IL6—autistic disorder	0.000251	0.000393	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DRB1—autistic disorder	0.00025	0.000391	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—IL6—autistic disorder	0.00025	0.000391	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—HRAS—autistic disorder	0.000248	0.000386	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—COMT—autistic disorder	0.000247	0.000386	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GRM5—autistic disorder	0.000247	0.000385	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VIP—autistic disorder	0.000247	0.000385	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—GSTP1—autistic disorder	0.000246	0.000384	CbGpPWpGaD
Everolimus—MTOR—Immune System—ITGA4—autistic disorder	0.000246	0.000384	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—MAOA—autistic disorder	0.000246	0.000383	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ADRB2—autistic disorder	0.000245	0.000383	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	0.000244	0.000381	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	0.000243	0.000379	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—MAPK1—autistic disorder	0.000242	0.000378	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PRKCB—autistic disorder	0.000241	0.000377	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OXTR—autistic disorder	0.000239	0.000373	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—EGF—autistic disorder	0.000238	0.000371	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS2—autistic disorder	0.000237	0.000371	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—autistic disorder	0.000237	0.00037	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SCT—autistic disorder	0.000237	0.00037	CbGpPWpGaD
Everolimus—MTOR—Disease—CALCA—autistic disorder	0.000235	0.000367	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AVP—autistic disorder	0.000231	0.00036	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APC—autistic disorder	0.00023	0.000359	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IGF2—autistic disorder	0.00023	0.000358	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—EGF—autistic disorder	0.000228	0.000356	CbGpPWpGaD
Everolimus—FKBP1A—Disease—EGF—autistic disorder	0.000227	0.000355	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—MAPK1—autistic disorder	0.000227	0.000354	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—autistic disorder	0.000227	0.000354	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—GSTM1—autistic disorder	0.000226	0.000353	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GABBR1—autistic disorder	0.000226	0.000353	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADM—autistic disorder	0.000226	0.000353	CbGpPWpGaD
Everolimus—MTOR—Immune System—PRL—autistic disorder	0.000225	0.000351	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	0.000223	0.000348	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EIF4E—autistic disorder	0.000222	0.000346	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDE4B—autistic disorder	0.00022	0.000344	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PLA2G4A—autistic disorder	0.000217	0.000338	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OPRM1—autistic disorder	0.000213	0.000333	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ACADSB—autistic disorder	0.000212	0.00033	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—INPP1—autistic disorder	0.000212	0.00033	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MEF2C—autistic disorder	0.000211	0.000329	CbGpPWpGaD
Everolimus—MTOR—Disease—PRL—autistic disorder	0.000208	0.000324	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ITGB3—autistic disorder	0.000206	0.000321	CbGpPWpGaD
Everolimus—FKBP1A—Disease—SERPINE1—autistic disorder	0.0002	0.000312	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GZMB—autistic disorder	0.000195	0.000304	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—BCL2—autistic disorder	0.000192	0.0003	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR2A—autistic disorder	0.000192	0.0003	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR1B—autistic disorder	0.000189	0.000295	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OXT—autistic disorder	0.000189	0.000295	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—BTD—autistic disorder	0.000189	0.000294	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—IL6—autistic disorder	0.000186	0.00029	CbGpPWpGaD
Everolimus—MTOR—Immune System—MEF2C—autistic disorder	0.000183	0.000286	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TSC2—autistic disorder	0.000182	0.000285	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—HRAS—autistic disorder	0.000182	0.000284	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LEP—autistic disorder	0.000178	0.000278	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APOE—autistic disorder	0.000178	0.000278	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD1—autistic disorder	0.000176	0.000275	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TSC1—autistic disorder	0.000176	0.000275	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTGS2—autistic disorder	0.000175	0.000273	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—IL6—autistic disorder	0.000174	0.000272	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NTRK2—autistic disorder	0.000171	0.000267	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD3—autistic disorder	0.00017	0.000266	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PRKCB—autistic disorder	0.000168	0.000263	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL5—autistic disorder	0.000167	0.00026	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-A—autistic disorder	0.000166	0.000259	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CALCA—autistic disorder	0.000165	0.000257	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PIK3CG—autistic disorder	0.000161	0.000251	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APC—autistic disorder	0.000161	0.000251	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TDO2—autistic disorder	0.00016	0.00025	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—POMC—autistic disorder	0.00016	0.00025	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PTEN—autistic disorder	0.000159	0.000249	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EGF—autistic disorder	0.000159	0.000248	CbGpPWpGaD
Everolimus—MTOR—Immune System—TSC2—autistic disorder	0.000159	0.000248	CbGpPWpGaD
Everolimus—MTOR—Disease—MTHFR—autistic disorder	0.000154	0.00024	CbGpPWpGaD
Everolimus—MTOR—Disease—HLA-A—autistic disorder	0.000153	0.00024	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—POMC—autistic disorder	0.000153	0.000239	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PTEN—autistic disorder	0.000153	0.000239	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTEN—autistic disorder	0.000152	0.000238	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DRB1—autistic disorder	0.000152	0.000237	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DHCR7—autistic disorder	0.000151	0.000235	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IGF1—autistic disorder	0.000147	0.00023	CbGpPWpGaD
Everolimus—MTOR—Disease—TSC2—autistic disorder	0.000146	0.000229	CbGpPWpGaD
Everolimus—MTOR—Immune System—PRKCB—autistic disorder	0.000146	0.000228	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRL—autistic disorder	0.000146	0.000227	CbGpPWpGaD
Everolimus—MTOR—Disease—APOE—autistic disorder	0.000143	0.000224	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EXT1—autistic disorder	0.000143	0.000223	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC6A8—autistic disorder	0.000143	0.000223	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SERPINE1—autistic disorder	0.00014	0.000219	CbGpPWpGaD
Everolimus—MTOR—Immune System—EGF—autistic disorder	0.000138	0.000216	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADRB2—autistic disorder	0.000138	0.000216	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DAO—autistic disorder	0.000136	0.000213	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS2—autistic disorder	0.000134	0.000208	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—UPB1—autistic disorder	0.000131	0.000204	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AVP—autistic disorder	0.00013	0.000202	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—MAPK1—autistic disorder	0.000129	0.000202	CbGpPWpGaD
Everolimus—MTOR—Disease—APC—autistic disorder	0.000129	0.000202	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IGF2—autistic disorder	0.000129	0.000202	CbGpPWpGaD
Everolimus—MTOR—Disease—EGF—autistic disorder	0.000128	0.0002	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MAPK1—autistic disorder	0.000124	0.000193	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PLA2G4A—autistic disorder	0.000122	0.00019	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ASMT—autistic disorder	0.000122	0.00019	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTM5—autistic disorder	0.000122	0.00019	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MEF2C—autistic disorder	0.000119	0.000185	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ITGB3—autistic disorder	0.000116	0.00018	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC25A12—autistic disorder	0.000114	0.000178	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL2—autistic disorder	0.000113	0.000177	CbGpPWpGaD
Everolimus—MTOR—Disease—SERPINE1—autistic disorder	0.000112	0.000176	CbGpPWpGaD
Everolimus—MTOR—Immune System—BCL2—autistic disorder	0.000112	0.000175	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC19A1—autistic disorder	0.000111	0.000174	CbGpPWpGaD
Everolimus—MTOR—Immune System—IFNG—autistic disorder	0.000111	0.000173	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR2A—autistic disorder	0.000108	0.000168	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTEN—autistic disorder	0.000107	0.000166	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HRAS—autistic disorder	0.000104	0.000162	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TSC2—autistic disorder	0.000103	0.00016	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LEP—autistic disorder	0.0001	0.000157	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOE—autistic disorder	0.0001	0.000157	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HRAS—autistic disorder	9.98e-05	0.000156	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6—autistic disorder	9.95e-05	0.000155	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HRAS—autistic disorder	9.94e-05	0.000155	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADSL—autistic disorder	9.91e-05	0.000155	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL2—autistic disorder	9.86e-05	0.000154	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—autistic disorder	9.82e-05	0.000153	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—XDH—autistic disorder	9.72e-05	0.000152	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NPAS2—autistic disorder	9.54e-05	0.000149	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—STX1A—autistic disorder	9.54e-05	0.000149	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6—autistic disorder	9.51e-05	0.000148	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCB—autistic disorder	9.46e-05	0.000148	CbGpPWpGaD
Everolimus—MTOR—Immune System—PTEN—autistic disorder	9.27e-05	0.000145	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TCN2—autistic disorder	9.21e-05	0.000144	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APC—autistic disorder	9.06e-05	0.000141	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PIK3CG—autistic disorder	9.06e-05	0.000141	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EGF—autistic disorder	8.95e-05	0.00014	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADA—autistic disorder	8.79e-05	0.000137	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MAPK1—autistic disorder	8.67e-05	0.000135	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—POMC—autistic disorder	8.62e-05	0.000135	CbGpPWpGaD
Everolimus—MTOR—Disease—PTEN—autistic disorder	8.56e-05	0.000134	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IGF1—autistic disorder	8.29e-05	0.000129	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—RORA—autistic disorder	8.01e-05	0.000125	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SERPINE1—autistic disorder	7.87e-05	0.000123	CbGpPWpGaD
Everolimus—MTOR—Immune System—MAPK1—autistic disorder	7.54e-05	0.000118	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MAOB—autistic disorder	7.51e-05	0.000117	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TPH2—autistic disorder	6.98e-05	0.000109	CbGpPWpGaD
Everolimus—MTOR—Disease—MAPK1—autistic disorder	6.96e-05	0.000109	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HRAS—autistic disorder	6.96e-05	0.000109	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DPYD—autistic disorder	6.87e-05	0.000107	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6—autistic disorder	6.66e-05	0.000104	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CACNA1C—autistic disorder	6.39e-05	9.97e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL2—autistic disorder	6.37e-05	9.95e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—HRAS—autistic disorder	6.05e-05	9.45e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTEN—autistic disorder	6e-05	9.36e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DHFR—autistic disorder	5.81e-05	9.07e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6—autistic disorder	5.79e-05	9.04e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—HRAS—autistic disorder	5.59e-05	8.72e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6—autistic disorder	5.35e-05	8.35e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAPK1—autistic disorder	4.87e-05	7.61e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP19A1—autistic disorder	4.55e-05	7.1e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—COMT—autistic disorder	4.23e-05	6.6e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTP1—autistic disorder	4.21e-05	6.57e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MAOA—autistic disorder	4.2e-05	6.56e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CAT—autistic disorder	4.1e-05	6.39e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HRAS—autistic disorder	3.91e-05	6.11e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.87e-05	6.04e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTM1—autistic disorder	3.87e-05	6.04e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6—autistic disorder	3.75e-05	5.85e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GPX1—autistic disorder	3.7e-05	5.78e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MTHFR—autistic disorder	3.42e-05	5.34e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOE—autistic disorder	3.18e-05	4.97e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.87e-05	4.48e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—POMC—autistic disorder	2.73e-05	4.27e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—autistic disorder	2.18e-05	3.4e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTEN—autistic disorder	1.9e-05	2.97e-05	CbGpPWpGaD
